Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSA
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare ISOVUE-250 and VISIPAQUE 270 for motion artifact and
pain following intraarterial injection for peripheral DSA.